BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3739Biotechnology
$7.88 −$0.81 (-9.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.88 0.00%
Open$8.52
Prev close$8.69
Day range$7.84 – $9.13
Volume419.1K
Market cap$203.65M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-0.4x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average -1.8x

Price / book1.6x
CheapRich

Near the top of its 5-year range · 91st percentile, 5-year average 0.6x

#2632 of 5328 stocks by PB (1 = cheapest)

P/E over five years

-22x-14x-5x3xOct '21Jun '23Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$33.15
Price vs. fair value-76.2%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.61 – 0.56 91% (pricier than usual) #2632 of 5328 (1 = cheapest)
PE -0.45 -2.74 -1.83 92% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on FTH.

Sign in to join the discussion.

Scroll to Top